Literature DB >> 27078265

Selective induction of anti-inflammatory monocyte-platelet aggregates in a model of pulsatile blood flow at low shear rates.

Yuji Takeda1,2, Mikio Marumo1, Hidetoshi Nara2, Zhong-Gang Feng3, Hironobu Asao2, Ichiro Wakabayashi1.   

Abstract

In patients with cardiovascular abnormalities or immunological disorders, an increased number of circulating leukocyte-platelet aggregates is observed. Leukocyte-platelet aggregates play an essential role in linking the hemostatic and immune systems. High shear stress and pro-coagulant and pro-inflammatory stimulants are known to activate platelets and promote the formation of aggregates. Pulsatile blood flow under low shear stress can also induce platelet activation in comparatively mild conditions. However, the effect of such events on leukocyte-platelet aggregates has not yet been investigated. To determine whether low shear stress affects the formation of aggregates, we established a simple "inverting rotation" method of inducing periodic changes in the direction of blood flow in combination with low shear stress. We demonstrated that after the inverting rotation treatment for 10-20 min more than 70% of monocytes selectively aggregated with platelets. The formation of monocyte-platelet complexes was inhibited by an anti-CD162 (PSGL-1) monoclonal antibody or a Ca(2+) chelator. The phagocytic activity of monocytes was augmented by inverting rotation, whereas phagocytosis mediated by granulocytes remained unaffected. Interestingly, the formation of monocyte-platelet complexes suppressed the production of pro-inflammatory cytokines such as interleukin (IL)-1β. At the same time, monocyte-platelet complexes augmented the expression of the anti-inflammatory cytokine IL-10. Our results suggest that platelet-bound monocytes show an anti-inflammatory phenotype under low shear stress conditions. Thus, our method provided new insights into the mechanisms of monocyte-platelet aggregate formation and regulation.

Entities:  

Keywords:  Inflammatory cytokine; PSGL-1; leukocyte-platelet aggregates; low shear stress; monocytes

Mesh:

Substances:

Year:  2016        PMID: 27078265     DOI: 10.3109/09537104.2016.1153616

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  6 in total

1.  Inflammatory and oxidative responses to disturbed blood flow in hypertensive men.

Authors:  Amanda S Storch; Helena N M Rocha; Vinicius P Garcia; Gabriel M S Batista; João Dario Mattos; Monique O Campos; Antonio Claudio L Nóbrega; Igor A Fernandes; Natalia G Rocha
Journal:  Hypertens Res       Date:  2019-06-28       Impact factor: 3.872

Review 2.  Relationship between Immunological Abnormalities in Rat Models of Diabetes Mellitus and the Amplification Circuits for Diabetes.

Authors:  Yuji Takeda; Tomoko Shimomura; Hironobu Asao; Ichiro Wakabayashi
Journal:  J Diabetes Res       Date:  2017-02-19       Impact factor: 4.011

Review 3.  The Dual Role of Platelets in the Cardiovascular Risk of Chronic Inflammation.

Authors:  Carlos Zamora; Elisabet Cantó; Sílvia Vidal
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

4.  Phenotypic and Functional Consequences of PLT Binding to Monocytes and Its Association with Clinical Features in SLE.

Authors:  Anaís Mariscal; Carlos Zamora; Berta Magallares; Tarek Carlos Salman-Monte; Mª Àngels Ortiz; Cesar Díaz-Torné; Iván Castellví; Héctor Corominas; Silvia Vidal
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

5.  The Influence of Temperature on the Antiviral Response of mIgM+ B Lymphocytes Against Hirame Novirhabdovirus in Flounder (Paralichthys olivaceus).

Authors:  Xiaoqian Tang; Xinbiao Ma; Jing Cao; Xiuzhen Sheng; Jing Xing; Heng Chi; Wenbin Zhan
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

Review 6.  Platelet-Monocyte Aggregates: Understanding Mechanisms and Functions in Sepsis.

Authors:  Guang Fu; Meihong Deng; Matthew D Neal; Timothy R Billiar; Melanie J Scott
Journal:  Shock       Date:  2021-02-01       Impact factor: 3.533

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.